🔎 Trials Near Me

홈 › 림프종 › 캘리포니아

캘리포니아의 림프종 임상 시험

림프종 관련 연구 40개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • City of Hope, Duarte
  • University of California, Irvine Medical Center - Hematology/Oncology, Orange
  • Stanford University School of Medicine, Stanford
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07192471

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

  • City of Hope Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07583810

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • UCSF Benioff Children's Hospital, San Francisco
피험자 모집 중1상
24 Months – 18 Years · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06441331

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
피험자 모집 중1/2상
25세 이하 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04094610

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • City of Hope, Duarte
  • Cedars-Sinai Medical Center, Los Angeles
  • Scripps Health, San Diego
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221500

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • City of Hope, Duarte
피험자 모집 중1상
18세 ~ 100세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Duarte
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
피험자 모집 중1/2상
12 Months – 21 Years · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, La Jolla
피험자 모집 중3상
18세 ~ 18세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • Saddleback Memorial Medical Center, Laguna Hills
  • Hoag Memorial Hospital, Newport Beach
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06624085

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

  • Stanford Medicine Cancer Center, Palo Alto
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07082803

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • City of Hope Cancer Center, Duarte
  • Valkyrie Clinical Trials, Los Angeles
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06084936

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • City of Hope National Medical Center, Duarte
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04588922

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

  • Children s Hospital of Los Angeles, Los Angeles
피험자 모집 중관찰 연구건강한 지원자 환영
5세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05237986

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • University of California-Irvine Medical Center, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA) Medical Center, Los Angeles
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

  • City of Hope, Duarte
  • Sarcoma Oncology Research Center, Santa Monica
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06678659

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • City of Hope, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06528301

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

  • Stanford University, Palo Alto
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06340737

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA), Los Angeles
  • University of California, Irvine, Orange
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT07188558

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07628634

DALY II USA/ MB-CART2019.1 for DLBCL

  • UC San Diego Health, La Jolla
  • Stanford University, Stanford
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • City of Hope, Duarte
  • University of California, San Francisco, San Francisco
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT05131022

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site, Duarte
  • Dren Investigational Site, Irvine
  • Dren Investigational Site, Redwood City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05475925

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • UC San Diego Moores Cancer Center, La Jolla
  • University of California, San Francisco, San Francisco
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 1. 업데이트됨 · NCT05663502

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

  • Stanford Medical Center, Stanford
피험자 모집 중2상
15세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT06954805

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • City of Hope Comprehensive Cancer Center, Duarte
  • Kaiser Permanente-Oakland, Oakland
  • Lucile Packard Children's Hospital Stanford University, Palo Alto
  • 외 1개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • City of Hope, Duarte
  • Providence St. John's Health Center, Santa Monica
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
  • 외 1개
피험자 모집 중1/2상
12세 ~ 95세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04329728

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

  • City of Hope National Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06915246

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • City of Hope, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 20. 업데이트됨 · NCT04830137

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

  • Stanford, Stanford
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT06510361

Pediatric PET/MR Image Registry

  • Stanford University, School of Medicine, Palo Alto
피험자 모집 중관찰 연구
40세 이하 · 모든 성별 · 2026. 2. 9. 업데이트됨 · NCT03458520

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

  • City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 28. 업데이트됨 · NCT05371132

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente-San Francisco, San Francisco
피험자 모집 중3상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 1. 13. 업데이트됨 · NCT05006482

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2025. 10. 14. 업데이트됨 · NCT06520098

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • City of Hope Medical Foundation, Duarte
  • University of Southern California, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 22. 업데이트됨 · NCT04234048

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

  • University of California, Davis, Sacramento
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 8. 7. 업데이트됨 · NCT06343311

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.